Private Capital Advisors’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$253K Sell
26,853
-125
-0.5% -$999 0.02% 68
2026
Q2
$236K Hold
26,978
– – 0.02% 67
2026
Q1
$207K Buy
+26,978
New +$185K 0.02% 67

Other funds holding IBRX

Private Capital Advisors's IBRX Position: Q3 2026 in Review

Private Capital Advisors reduced its ImmunityBio (IBRX) stake by 0.46% in Q3 2026, selling an estimated $999 and leaving 26,853 shares worth $253K. The position accounts for 0.02% of the portfolio, ranked #68.

Private Capital Advisors first reported a position in IBRX in Q1 2026 and has held it in 3 quarters since. 407 funds tracked by Wall St. Rank hold IBRX as of Q3 2026.

  • Private Capital Advisors held 26,853 shares of ImmunityBio worth $253K as of Q3 2026.
  • Private Capital Advisors sold 125 ImmunityBio shares in Q3 2026, an estimated $999.
  • ImmunityBio made up 0.02% of Private Capital Advisors's portfolio in Q3 2026, its #68 holding.
  • Private Capital Advisors first reported a position in ImmunityBio in Q1 2026 and has held it in 3 quarters since.
  • 407 funds tracked by Wall St. Rank held ImmunityBio as of Q3 2026.

Based on Private Capital Advisors's 13F filing for Q3 2026, filed 6 Oct 2026.